Antibodies News and Research

RSS

New drug shows promise to reverse treatment resistance in advanced multiple myeloma

Researchers at the VU University Medical Center in the Netherlands have tested a new drug in patient samples and mice with multiple myeloma and discovered that it was effective even in advanced disease - a point when many patients currently run out of options.

27 Mar 2020

Research offers hope for increasing the robustness of vaccine response in older people

Research just published by the Linterman lab shows that the immune system of older mice can be given a helping hand by applying immunology expertise and some genital wart treatment (don't try this at home just yet)!

27 Mar 2020

Scientists uncover key molecular mechanism underlying different aspects of sepsis

Sepsis is a life-threatening condition that kills millions annually; it is poorly understood and has no specific treatment.

27 Mar 2020

A promising strategy to overcome drug resistance developed by blood cancer cells

In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.

27 Mar 2020

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Today Berkeley Lights, Inc., announced the GEPAD with the aim to accelerate the discovery of neutralizing antibodies from patient blood samples.

From Bruker Cellular Analysis 26 Mar 2020

Deleting a gene prevents Type 1 diabetes in mice by disguising insulin-producing cells

Scientists have innovated a potential method of preventing Type 1 diabetes in those at high risk.

26 Mar 2020

Drebrin autoantibodies trigger epilepsy

Certain forms of epilepsy are accompanied by inflammation of important brain regions. Researchers at the University of Bonn have now identified a mechanism that explains this link.

24 Mar 2020

Projects to develop COVID-19 vaccines receive U.K. gov’t funding

The U.K. government backs six projects aimed to fight the coronavirus outbreak, promising $23 million (£20 million) in funding. The projects, including two focused on vaccination trials, will help fast track the development of a vaccine to stop the spread of the coronavirus, leading to the death of more than 16,500 people across the globe.

24 Mar 2020

Celltrion announces key milestones in its efforts to fight COVID-19

Celltrion Group today announced key milestones in its efforts to fight the 2019 novel coronavirus (COVID-19) pandemic.

23 Mar 2020

CEL-SCI collaborates with UGA Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy

CEL-SCI Corporation announced today it has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.

23 Mar 2020

NYUAD researchers develop new microfluidic platform to perform cancer liquid biopsies

Cancer is one of the leading causes of death worldwide, and has been found to have a significantly higher rate of survival when diagnosed at early stages, before metastasis.

23 Mar 2020

The COVID-19 vaccine pipeline

Major nations are in a race to make an effective vaccine that could help treat the novel coronavirus infection COVID-19. As hundreds of thousands are infected across the world and over sixteen thousand killed, the pandemic shows no signs of relenting.

23 Mar 2020

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

James Diaz, MD, MHA, MPH & TM, Dr PH, Professor and Head of Environmental Health Sciences at LSU Health New Orleans School of Public Health, has proposed a possible explanation for the severe lung complications being seen in some people diagnosed with COVID-19.

23 Mar 2020

DSI alumni use computational design to quickly discover treatments for COVID-19

Two graduates of the Data Science Institute at Columbia University are using computational design to quickly discover treatments for the coronavirus.

21 Mar 2020

Avantor launches new Protein A Chromatography Resin – PROchievA – that provides supply chain flexibility and improves downstream purification performance for monoclonal antibodies (mAbs) production

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAbs production.

From Avantor 20 Mar 2020

Targeting PI3Kβ alone and with combination therapy in PTEN-deficient tumors

The cover for issue 11 of Oncotarget features Figure 6, "Effects of AZD8186 in combination with anti-PD1 on syngeneic models," by Owusu-Brackett, et al.

18 Mar 2020

Who should stay at home due to coronavirus?

COVID-19 is a spreading viral illness, mostly mild but fatal in the sick and elderly. At present, it has affected almost 200,000 people, with nearly 8,000 deaths worldwide. Governments around the world are formulating and executing new guidelines to control the spread of the virus. In the latest guidelines, pregnant women join the list of individuals who must stay away from all social contact for 12 weeks to limit the spread of the virus and deaths due to the illness.

17 Mar 2020

Antibodies News and Research

New drug shows promise to reverse treatment resistance in advanced multiple myeloma

Research offers hope for increasing the robustness of vaccine response in older people

Scientists uncover key molecular mechanism underlying different aspects of sepsis

A promising strategy to overcome drug resistance developed by blood cancer cells

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Deleting a gene prevents Type 1 diabetes in mice by disguising insulin-producing cells

Drebrin autoantibodies trigger epilepsy

Projects to develop COVID-19 vaccines receive U.K. gov’t funding

Celltrion announces key milestones in its efforts to fight COVID-19

CEL-SCI collaborates with UGA Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy

NYUAD researchers develop new microfluidic platform to perform cancer liquid biopsies

The COVID-19 vaccine pipeline

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

DSI alumni use computational design to quickly discover treatments for COVID-19

Avantor launches new Protein A Chromatography Resin – PROchievA – that provides supply chain flexibility and improves downstream purification performance for monoclonal antibodies (mAbs) production

Targeting PI3Kβ alone and with combination therapy in PTEN-deficient tumors

Who should stay at home due to coronavirus?

New understanding of signaling molecule interleukin-2 can guide drug discovery efforts

Scientists use artificial intelligence to create new proteins unseen in nature

Max Planck researchers identify mechanistic basis of antigen receptor gene assembly

Immunology eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News